/ Print /

Kimberly Lenz, PharmD
Opinion: Substance use disorder privacy law limits both payers, prescribers
Two University of Massachusetts Medical School pharmacists make the case to reform or align 42 CFR Part 2 with HIPAA to better serve patients with substance use disorder.
Overview of depression and its management in children and adolescents
This review addresses the prevalence and management of major depressive disorder (MDD) in school-aged children and adolescents, including treatment guidelines and agents under investigation for this indication.